天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Which Diseases is Elagolix FDA-Approved For?

May 14,2024

Elagolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the management of moderate to severe pain associated with endometriosis. It is used to manage pain due to endometriosis (a condition in which the type of tissue that lines the uterus [womb] grows in other areas of the body and causes infertility, pain before and during menstrual periods, pain during and after sexual activity, and heavy or irregular bleeding).

elagolix

In 2018, the U.S. Food and Drug Administration (FDA) approved elagolix (Orilissa?) for treating pain associated with endometriosis—the first and only pill specifically approved for endometriosis pain relief. In 2020, the FDA also approved the drug Oriahnn?, which contains elagolix, for treating heavy menstrual bleeding caused by uterine fibroids. Oriahnn? is the first pill approved specifically for this symptom.

  • Related articles
  • Related Qustion
See also
4

Triphenyl phosphite can be used as the oxidation inhibitor and the stablizer of many polymkeric substance.....

Jan 10,2025API
4

Methylamine hydrochloride is used as a synthetic raw material or pharmaceutical intermediate component in the manufacture of pharmaceuticals.....

May 14,2024API

elagolix

834153-87-6

elagolix manufacturers

  • (R)-Elagolix
  • 834153-87-6 (R)-Elagolix
  • $32.00 / 1mg
  • 2024-11-19
  • CAS:834153-87-6
  • Min. Order:
  • Purity: 97.63%
  • Supply Ability: 10g
  • (R)-Elagolix
  • 834153-87-6 (R)-Elagolix
  • $32.00 / 1mg
  • 2024-11-19
  • CAS:834153-87-6
  • Min. Order:
  • Purity: 97.63%
  • Supply Ability: 10g
  • elagolix
  • 834153-87-6 elagolix
  • $0.00 / 1KG
  • 2024-10-25
  • CAS:834153-87-6
  • Min. Order: 1KG
  • Purity: 0.99
  • Supply Ability: 50MT/month